Company intelligence / Profile preview

Serologicals

Norcross, Georgia, USA
Ownership
Private
Employees
~1000
Development stage
Other
01

Overview

Serologicals Corporation was a leading global provider of biological products, enabling technologies, and services to the life sciences industry. The company specialized in developing and manufacturing products used in the research, development, and manufacturing of biopharmaceuticals, as well as in molecular diagnostics. Its portfolio included high-quality cell culture supplements, such as the proprietary Ex-Cyte growth enhancer, and a vast array of antibodies and reagents through its subsidiaries Chemicon and Upstate. Serologicals was a key supplier of animal-derived proteins, including bovine serum albumin, which are critical for vaccine and drug production. In 2006, the company was acquired by Millipore Corporation for approximately $1.4 billion, a move that significantly expanded Millipore's presence in the drug discovery and upstream bioprocessing markets. Following Millipore's subsequent acquisition by Merck KGaA, the Serologicals product lines were integrated into what is now MilliporeSigma.

Modalities
AntibodyProteinRecombinant protein
Industry
Chemicals & Materials
02

Partnerships

Luminex Corporation

Beyond the preview

Go deeper on Serologicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serologicals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call